New treatment option for schizophrenia Reagila listed on PBS

Seqirus

6 September 2021 - Adults living with schizophrenia will have access to a new treatment option with Reagila (cariprazine), reimbursed on the PBS from 1 September 2021.

A new treatment for schizophrenia in adults, Reagila (cariprazine), was listedon the PBS on 1 September, providing patients with an additional treatment option. 

Approved in the US since 2015 and EU since 2017, Reagila is approved in over 52 countries for the treatment of schizophrenia in adults.

Read Seqirus press release

Michael Wonder

Posted by:

Michael Wonder